CRVS - Corvus Pharmaceuticals Inc. (CRVS) CEO Richard Miller on Q4 2021 Results - Earnings Call Transcript
Corvus Pharmaceuticals, Inc. (CRVS) Q4 2021 Earnings Conference Call March 10, 2022 04:30 PM ET Company Participants Richard Miller - Co-Founder, President and CEO Leiv Lea - CFO Zack Kubow - Investor Relations, Real Chemistry Conference Call Participants Li Watsek - Cantor Fitzgerald Mara Goldstein - Mizuho Roger Song - Jefferies. Arthur He - H.C. Wainwright Presentation Operator Greetings. Welcome to Corvus Pharmaceuticals Fourth Quarter 2021 Earnings Conference Call. [Operator Instructions] Please note, this conference is being recorded. I will now turn the conference over to Zack Kubow of Real Chemistry. Thank you. You may begin. Zack Kubow Thank you, operator, and good afternoon, everyone. Thanks for joining us for the Corvus Pharmaceuticals fourth quarter 2021 business update and financial results conference call. On the call to discuss the results and business updates are Richard Miller, Chief Executive Officer; and Leiv Lea, Chief Financial Officer. The executive team will open
For further details see:
Corvus Pharmaceuticals, Inc. (CRVS) CEO Richard Miller on Q4 2021 Results - Earnings Call Transcript